Avelox

Medicinal product

(Invented) name

Avelox

Active substance (s)

Moksifloksacinas

Strength

400 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01MA14, Moxifloxacin

Marketing authorisation holder

UAB Adeofarma, Lietuva

Date of authorisation

2018-07-20

Date of renewal

Documents

0701_Avelox_PZPL_2018-07-20.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Moksifloksacinas	400 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99827	85935	1085935	lizdinė plokštelė	N5		Receptinis	LT/L/18/0701/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2018-07-20	Registruotas